No, a prostate biopsy does not cause or spread prostate cancer in the vast majority of patients. While extremely rare cases of cancer cell seeding have been reported in medical literature, decades of research show that the benefits of diagnosing prostate cancer far outweigh this exceptionally small risk.
On this Page
Does a Prostate Biopsy Spread Prostate Cancer?
One of the biggest fears among men advised to undergo a prostate biopsy is that the needle might “disturb” the cancer and cause it to spread throughout the body.
This concern is understandable, but it is largely a myth.
Modern medical evidence shows that prostate biopsies do not cause prostate cancer, nor do they significantly increase the risk of cancer spreading. Millions of prostate biopsies have been performed worldwide over the past several decades, and they remain the gold standard for confirming whether cancer is present.
Without a biopsy, doctors cannot accurately determine whether suspicious findings on a PSA blood test or MRI are actually cancer.
Why Do People Believe This Myth?
The misconception usually comes from hearing that a biopsy needle passes through the prostate and wondering whether it could carry cancer cells elsewhere.
Technically, this phenomenon is called needle tract seeding, the movement of tumour cells along the path of a biopsy needle.
While this can occur with a few other cancers, it is extraordinarily rare in prostate cancer. More importantly, the available scientific evidence shows that it is not a reason to avoid a prostate biopsy.
What Does the Research Actually Say?
Researchers have specifically investigated whether prostate biopsies spread cancer.
A comprehensive review published in the BJU International examined decades of published studies on prostate biopsy and needle tract seeding. Researchers identified only 42 reported cases despite the enormous number of prostate biopsies performed worldwide. They concluded that needle tract seeding is rare (estimated at less than 1%) and stated that patients should not avoid biopsy because the benefits of diagnosis greatly outweigh the potential risks.
Even older studies that documented isolated cases found that these were uncommon and usually occurred in patients with large, advanced tumours, rather than those undergoing routine diagnosis.
In other words, the available evidence does not support the idea that a biopsy causes prostate cancer to spread throughout the body.
Can a Prostate Biopsy Cause Cancer?
Absolutely not. A biopsy cannot create cancer. The procedure simply removes tiny samples of prostate tissue so that a pathologist can examine them under a microscope.
Cancer develops because of genetic mutations within prostate cells over many years—not because a needle enters the prostate.
If cancer is discovered after a biopsy, it means the cancer was already present before the procedure. The biopsy merely confirms its existence.
The Real Risk: Delaying Diagnosis
Ironically, the greatest danger is often avoiding a biopsy altogether.
If prostate cancer is caught early, many men have excellent treatment options and survival outcomes.
However, delaying diagnosis because of misinformation may allow the cancer to grow beyond the prostate, making treatment more complex.
A biopsy helps doctors determine:
- Whether cancer is actually present
- How aggressive the Gleason grade group is
- Whether treatment is needed
- Which treatment option is most appropriate
Without these answers, doctors are essentially treating in the dark.
Modern Biopsies Are Safer Than Ever
Today’s prostate biopsies have improved significantly.
Many hospitals now perform transperineal prostate biopsies, where the needle passes through the skin between the scrotum and anus rather than through the rectum.
This approach is increasingly recommended because it greatly reduces the risk of infection while maintaining excellent diagnostic accuracy.
Advances in MRI-guided targeting, ultrasound imaging, and biopsy equipment have also made prostate biopsy more precise than ever before.
Conclusion
The belief that prostate biopsies spread prostate cancer has persisted for years, but modern medical evidence tells a different story. Extensive research has found that while needle tract seeding is an exceptionally rare event, it is not a reason to avoid a biopsy.
If your doctor recommends a prostate biopsy after an abnormal PSA test, MRI, or physical examination, remember that the procedure is designed to provide answers—not create new problems. Early diagnosis remains one of the most effective ways to detect clinically significant prostate cancer and guide timely treatment.
The takeaway is simple: a prostate biopsy does not cause prostate cancer, and avoiding one because of misinformation could delay a diagnosis when treatment is most effective.
FAQs
Can a biopsy wake up dormant prostate cancer?
No. There is no scientific evidence that a biopsy activates or accelerates prostate cancer.
Can biopsy needles spread cancer cells?
In extremely rare circumstances, cancer cells may be displaced along the needle tract. However, published evidence shows this occurs very infrequently and has not been shown to outweigh the life-saving value of obtaining an accurate diagnosis.
Should I avoid a biopsy because of this risk?
No. Medical experts continue to recommend prostate biopsy whenever clinically indicated because the benefits of early diagnosis greatly exceed the exceptionally small risk of needle tract seeding.
